The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies
  • Mind Cure Establishes Psychedelic Compound Research Program
  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
  • Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
  • Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger

TSI Exclusive

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

2021-01-21 PSW Editor

Mind Cure announces a CAD$10 million bought deal financing at a unit price of CAD$0.60. Proceeds will be directed toward product research development and related tech initiatives like its iSTRYM digital therapeutics platform.

Mind Cure Establishes Psychedelic Compound Research Program

2020-12-08 TSI Editor

Mind Cure Health will be focus its psychedelics R&D on psilocybin, ketamine and ibogaine. The Company will pursue both pain-based and mental health applications.

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

2020-08-31 Jeff Nielson

A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

2020-07-06 Jeff Nielson

The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

2020-06-30 TSI Editor

Eleusis Therapeutics is a private psychedelics company that is turning a lot of heads with its research on micro-doses of LSD as a treatment for Alzheimer's.

What Does Field Trip Psychedelics Offer Investors?

2020-06-30 TSI Editor

Field Trip Psychedelics has just announced a letter of intent to go public via RTO.

Canadians More Receptive To Use Of Psilocybin For The Terminally Ill: New Poll

2020-06-30 TSI Editor

Canadians are rapidly warming up to the idea of using psilocybin to reduce distress among the terminally ill.

ATAI Life Sciences Forges Premier Psychedelics R&D Platform

2020-06-19 Jeff Nielson

ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.

What A Trip! Psychedelics Stocks Flying High

2020-05-22 TSI Editor

Several psychedelics companies have generated impressive returns for investors in recent weeks.

Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger

2020-01-22 Jeff Nielson

In a "bad" year for the emerging cannabis industry, global cannabis sales rose by 48% in 2019. That's not bad.

Is CBD ‘Harmful’ to Our Liver? No.

2020-01-20 Jeff Nielson

The U.S. Food and Drug Administration is claiming that CBD poses significant risks to the human liver. Nonsense.

Industry Leaders Leading Turnaround in Marijuana Stocks?

2020-01-16 Jeff Nielson

The largest U.S.-based cannabis company and the largest Canadian cannabis company have both seen their stock make strong moves. Will other cannabis companies follow?

The U.S. Cannabis Revolution: Two Charts

2020-01-08 Jeff Nielson

As the U.S. Cannabis Revolution unfolds, over 90% of Americans now want cannabis legalized (at least) for medical purposes. Attention Congress.

A New Era Begins For Retail Cannabis In Ontario

2020-01-07 TSI Editor

The new cannabis store licensing system has commenced in Ontario. Total retail cannabis stores could multiply by nearly a factor of 10 in 2020.

The Year of Opportunity: Marijuana Stocks to Watch in 2020

2019-12-30 Jeff Nielson

The 2019 meltdown in marijuana stocks is now an opportunity for value investors in 2020.

  • 1
  • 2
  • 3
  • 4
  • ...
  • 31
  • Next
Join our Newsletter
 Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

2021-01-21
Mind Cure announces a CAD$10 million bought deal financing at a unit price of CAD$0.60. Proceeds will be directed toward product research development and related tech initiatives like its iSTRYM digital therapeutics platform.

Mind Cure Establishes Psychedelic Compound Research Program

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

TSI Exclusive
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2022, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor